Clinical trial completed – Presented at CX

Endovab are happy to announce that the clinical investigation for the Liungman Guidewire Fixator (LGF) has been successfully completed. The LGF is a completely new medical device, first of its kind to offer temporarily anchoring of a guidewire in a target artery while maintaining blood-flow.

Professor Anders Wanhainen presents the clinical data from the LGF study and the latest facilitated f/b-EVAR research at the Charing Cross Symposium. The LGF presentation is held in the Olympia Room, at the Innovation Showcase stage on Wednesday the 27th of April at 08.50 - 09.00.
Do you want to know more? We will off course be there if anyone likes to see or feel the LGF device. We encourage all feedback from the vascular scientific society so please let us know if you have queries or suggestions regarding the new f/b-EVAR technique.

News archive


Last news